Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma

doi:10.3748/wjg.v28.i14.1479

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6183)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

334

WORD

HTML

2841

Figures (1-5)

382

Tables (1-3)

441

Sum=4091

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

301

Download

438

Sum=739

Publishing Process of This Article

Item

Count

Browse

450

Download

903

Sum=1353

Apr 14, 2022 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 14, 2022; 28(14): 1479-1493
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1479

Full Size Figure Download Figure

Figure 1 Patient recruitment process.

Citation: Che F, Xu Q, Li Q, Huang ZX, Yang CW, Wang LY, Wei Y, Shi YJ, Song B. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma. World J Gastroenterol 2022; 28(14): 1479-1493
URL: https://www.wjgnet.com/1007-9327/full/v28/i14/1479.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i14.1479